Jabra Enhance Select 200 vs Sony CRE-C10
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

Jabra Enhance Select 200
The Jabra Enhance Select 200 is a premium-priced OTC hearing aid that earned a B grade with a SoundScore of 3.9/5 in our lab testing, placing it in the top 35% of the OTC hearing aid category. At $1,695, this behind-the-ear device offers solid performance in several key areas, though it faces stiff competition from higher-scoring alternatives at similar price points. In our testing, this device showed particular strength in speech clarity during quiet listening situations, scoring 3.5/5—0.67 points above the category average. Own-voice comfort was another highlight at 3.4/5, finishing 0.89 points above average, which suggests users may find their own voice sounds more natural compared to many competitors. Music streaming scored 2.6/5, which is above the category average by 0.68 points but still only mixed in absolute terms. The device's limitations become apparent in challenging listening environments. Speech in noise scored just 1.4/5, slightly below the category average and low in absolute terms—a consideration for users who frequently encounter noisy restaurants or social gatherings. Feedback handling scored 4.0/5, which is strong in absolute terms though 0.54 points below the category average. The Enhance Select 200 has earned Expert's Choice Awards in both 2023 and 2024, reflecting its reliable real-world performance. With Bluetooth streaming for both iPhone and Android, rechargeable batteries, and hands-free capability, it offers modern convenience features. However, shoppers should note that several competitors in this price range—including the Lucid Tala and Audicus Omni 2—scored notably higher in our testing. This device is best suited for users who prioritize speech clarity in quieter environments and own-voice comfort over performance in noisy situations.
Choice

Sony CRE-C10
The Sony CRE-C10 is an invisible-in-ear OTC hearing aid priced at $798, earning an A grade with a SoundScore of 4.2/5 in our lab testing. This places it at #12 of 65 devices in the OTC category, putting it in the top 17% of tested OTC hearing aids. Speech performance is where this device truly shines. Speech in quiet scores an excellent 4.5/5, a full 1.71 points above the category average of 2.79/5. Speech in noise performance at 2.9/5 is mixed in absolute terms, though still 1.39 points above the category average of 1.48/5. These speech clarity strengths have contributed to the CRE-C10 earning Expert's Choice recognition in both 2023 and 2024. The device does have notable limitations. Music streaming scores 0.0/5, which is 1.92 points below the category average—this device is not designed for audio entertainment. Feedback handling scores a solid 3.5/5 in absolute terms, though this is 1.04 points below the category average of 4.54/5. Own-voice comfort is mixed at 2.6/5, essentially matching the category average. The Sony CRE-C10 is best suited for consumers who prioritize speech understanding over streaming capabilities and want a discreet, invisible-in-ear form factor. Those who frequently stream music or media should consider alternatives like the Sony CRE-E10, which scores higher overall in this price range.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit